Vivelle and breast cancer in situ Patient Reports February 10, 2012

Vivelle Side Effects Report #5284702-3
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2006. Female patient, 62 years of age, was diagnosed with menopausal symptoms and was treated with Vivelle. After drug was administered, patient experienced the following side effects: breast cancer in situ, mastectomy . Vivelle dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, MEDROXYPROGESTERONE. Patient recovered.

Vivelle Side Effects Report #5374325-X
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 62 years of age, weighting 145.0 lb, was diagnosed with menopausal symptoms, hot flush, depression  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: arthritis , breast cancer in situ, breast infection, breast reconstruction , device breakage, dyspnoea, fatigue, foot operation, hypersensitivity. Vivelle dosage: 0.05 MG, UNK. During the same period patient was treated with PREMARIN, PROVERA, PREMPRO, LEXAPRO, CELEBREX. Patient recovered.

Vivelle Side Effects Report #5751606-9
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2008. Female patient, weighting 145.0 lb, was diagnosed with menopausal symptoms, hot flush, depression  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: arthritis , benign uterine neoplasm, breast cancer in situ, breast infection, breast reconstruction , depression , device breakage, dyspnoea, fatigue. Vivelle dosage: 0.05 MG, UNK. During the same period patient was treated with PREMARIN, PROVERA, PREMPRO, LEXAPRO, CELEBREX. Patient recovered.

Vivelle Side Effects Report #5810934-9
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on July 07, 2008. Female patient, weighting 150.0 lb, was diagnosed with menopausal symptoms, prophylaxis, menopause , hypertension and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain upper, angina pectoris, arrhythmia , biopsy breast, bladder disorder, blood potassium decreased, breast cancer in situ, breast cyst, breast hyperplasia. Vivelle dosage: 0.1 MG, UNK. During the same period patient was treated with ESTRADERM, PREMARIN, PROVERA, MEDROXYPROGESTERONE, HYDROCHLOROTHIAZIDE. Patient recovered.


Vivelle Side Effects Report #5692248-3
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 68 years of age, weighting 153.0 lb, was treated with Vivelle. After drug was administered, patient experienced the following side effects: breast calcifications, breast cancer in situ, breast hyperplasia, breast reconstruction , hyperlipidaemia, hypertension, injury, mammogram abnormal, mastectomy . Vivelle dosage: unknown. During the same period patient was treated with PROVERA, PREMPRO, ASPIRIN, FLOVENT, PAXIL, LEVOXYL, FOSAMAX. Patient was hospitalized. Patient recovered.

Vivelle Side Effects Report #5339087-0
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on May 05, 2006. Female patient, 59 years of age, weighting 175.9 lb, was treated with Vivelle. After drug was administered, patient experienced the following side effects: breast cancer in situ. Vivelle dosage: unknown. Patient recovered.

Vivelle Side Effects Report #5250760-5
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2007. Female patient, 51 years of age, weighting 195.0 lb, was diagnosed with sleep disorder  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abscess , anxiety , breast abscess, breast cancer in situ, breast cyst, breast microcalcification, breast tenderness, dysphonia, dyspnoea. Vivelle dosage: 0.025 MG/DAY, Q3 DAYS. During the same period patient was treated with PREMARIN, ALORA, CLIMARA, BELLERGAL. Patient recovered.

Vivelle Side Effects Report #5258458-4
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 26, 2007. Female patient was treated with Vivelle. After drug was administered, patient experienced the following side effects: anxiety , arrhythmia , breast cancer in situ, chest pain , electrocardiogram ambulatory abnormal, emotional distress, injury, intervertebral disc protrusion, laboratory test abnormal. Vivelle dosage: 0.05 MG/DAY, UNK. During the same period patient was treated with PREMARIN, CLIMARA, ESTRACE. Patient recovered.